Skip to main content
Santosh Pillai, DO, Psychiatry, Birmingham, AL

SantoshKumarPillaiDO

Psychiatry • Birmingham, AL

Psychiatrist

Join to view full profile

Dr. Pillai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pillai's full profile

Already have an account?

  • Office

    601 Beacon Parkway West
    Suite 201
    Birmingham, AL 35209
    Phone+1 205-870-3520
    Fax+1 205-870-3522

Summary

  • Dr. Santosh Pillai is a board-certified psychiatrist in Birmingham, AL. He received his medical degree from A.T. Still University, Kirksville College of Osteopathic Medicine in Missouri, and has been in practice for over 10 years. He is experienced in treating depression, bipolar, anxiety, schizophrenia, OCD, PTSD, and ADHD.

Education & Training

  • Henry Ford Health/Henry Ford Hospital
    Henry Ford Health/Henry Ford HospitalResidency, Psychiatry, 2009 - 2013
  • A. T. Still University Kirksville College of Osteopathic Medicine
    A. T. Still University Kirksville College of Osteopathic MedicineClass of 2008
  • Wayne State University School of Medicine
    Wayne State University School of MedicineMaster of Science, Basic Medical Science, 2001 - 2002
  • University of Michigan
    University of MichiganBachelor of Arts, Psychology & Pre-Med, 1996 - 2000

Certifications & Licensure

  • FL State Medical License
    FL State License 2013 - 2026
  • AL State Medical License
    AL State License 2022 - 2024
  • MI State Medical License
    MI State License 2008 - 2016
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • Top Physicians 2019 of Central Florida Orlando Family Magazine, 2019

Research History

  • Sub Investigator--An Open-label, long-term Safety Study of Rapastinel on Adjunctive Therapy in Patients with MDD --A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients with Major Depressive Disorder2018 - 2020
  • Principal Investigator--RECOVER Study: A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy, System as Adjunctive Therapy Versus a No Stimulation Control in subjects With Treatment-Resistant Depression2018 - 2020

Professional Memberships

Dr. Santosh Pillai, Dr. Santosh Pillai, DO, Dr. S Pillai, Dr. Santosh Kumar Pillai